ProQR Therapeutics (PRQR) Research & Development (2013 - 2026)
ProQR Therapeutics' Research & Development was -$14.72 million in the quarter ended Jun 30, 2026, compared with -$12.91 million a year earlier.
Powered by 
Analysis
ProQR Therapeutics (PRQR) Research & Development (2013 - 2026) Analysis & Trends
On a trailing twelve-month basis, ProQR Therapeutics' Research & Development was -$53.08 million through Jun 30, 2026; for the year ended Dec 31, 2025, it was -$50.54 million.
- In earlier years, Research & Development was -$39.35 million in the year ended Dec 31, 2024, -$27.2 million in the year ended Dec 31, 2023, -$53.61 million in the year ended Dec 31, 2022 and -$49.96 million in the year ended Dec 31, 2021.
- The figure for the quarter ended Jun 30, 2026 marks the lowest quarterly Research & Development since the quarter ended Sep 30, 2022.
- Per Business Quant data, PRQR's Research & Development in the three quarters before the quarter ended Jun 30, 2026 was -$13.85 million (quarter ended Mar 31, 2026), -$11.55 million (quarter ended Dec 31, 2025) and -$12.95 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 3.89 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.02 Bn |
| 10 | ProQR Therapeutics | 138.02 Mn | -322.63 Mn | - | 14.72 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.72 Mn |
| Mar 31, 2026 | 13.85 Mn |
| Dec 31, 2025 | 11.55 Mn |
| Sep 30, 2025 | 12.95 Mn |
| Jun 30, 2025 | 12.91 Mn |
| Mar 31, 2025 | 12.96 Mn |
| Dec 31, 2024 | 11.34 Mn |
| Sep 30, 2024 | 10.34 Mn |
| Jun 30, 2024 | 7.59 Mn |
| Mar 31, 2024 | 10.08 Mn |
| Dec 31, 2023 | 8.32 Mn |
| Sep 30, 2023 | 5.93 Mn |
| Jun 30, 2023 | 6.43 Mn |
| Mar 31, 2023 | 6.50 Mn |
| Dec 31, 2022 | 10.92 Mn |
| Sep 30, 2022 | 15.48 Mn |
| Jun 30, 2022 | 12.22 Mn |
| Mar 31, 2022 | 15.00 Mn |
| Dec 31, 2021 | 14.25 Mn |
| Sep 30, 2021 | 13.12 Mn |
API Access
ProQR Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=PRQR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "PRQR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=PRQR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();